OXTELLAR XR

Supernus Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Sep 15, 2026
Approval ID: aa610e56-1d1d-11e1-8bc2-0800200c9a66
Products: 3 registered
Version: 22

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use OXTELLAR XR safely and effectively. See full prescribing information for OXTELLAR XR . OXTELLAR XR (oxcarbazepine) extended-release tablets, for oral use Initial U.S. Approval: 2000

Quick Stats

Total Products3

Labelers2

Label Sections22

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.